Westfield Capital Management CO LP Moon Lake Immunotherapeutics Transaction History
Westfield Capital Management CO LP
- $21.2 Billion
- Q3 2024
A detailed history of Westfield Capital Management CO LP transactions in Moon Lake Immunotherapeutics stock. As of the latest transaction made, Westfield Capital Management CO LP holds 1,167,358 shares of MLTX stock, worth $57.5 Million. This represents 0.28% of its overall portfolio holdings.
Number of Shares
1,167,358
Previous 1,117,625
4.45%
Holding current value
$57.5 Million
Previous $49.1 Million
19.77%
% of portfolio
0.28%
Previous 0.25%
Shares
6 transactions
Others Institutions Holding MLTX
# of Institutions
124Shares Held
58.2MCall Options Held
52.2KPut Options Held
38K-
Bvf Inc San Francisco, CA21.8MShares$1.07 Billion34.86% of portfolio
-
Cormorant Asset Management, LP Boston, MA8.49MShares$418 Million30.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.98MShares$147 Million0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.77MShares$136 Million2.1% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.32MShares$114 Million0.02% of portfolio
About MoonLake Immunotherapeutics
- Ticker MLTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,925,600
- Market Cap $1.82B
- Description
- MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...